ALONE-AF: Discontinuing Long-Term Oral Anticoagulation After Successful AFib Ablation

The ALONE-AF study examined outcomes in atrial fibrillation (AF) patients who remained free of recurrence following catheter ablation. Researchers found that discontinuing oral anticoagulation (OAC) was associated with a lower risk of stroke, systemic embolism, or major bleeding compared to continued OAC. These findings, presented at the ESC Congress 2025, suggest that stopping OAC may offer a safer long-term strategy for select post-ablation AF patients. This could mark a meaningful shift in how clinicians approach anticoagulation management in this population.

In this interview, Dhanunjaya "DJ" Lakkireddy MBBS, FACC and Boyoung Joung, MD, PhD discuss "ALONE-AF: Discontinuing Long-Term Oral Anticoagulation After Successful AFib Ablation".

SUGGESTED MATERIALS:

1. New data on oral anticoagulation after successful ablation of atrial fibrillation (escardio.org website). 2025. Available at: https://www.escardio.org/The-ESC/Press-Office/Press-releases/New-data-on-oral-anticoagulation-after-successful-ablation-of-atrial-fibrillation#. Accessed 11/9/25.

Subscribe on Apple Podcasts | Subscribe to ACCEL